Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nolan Priedigkeit, M.D.

Concepts

This page shows the publications Nolan Priedigkeit has written about Cell Line, Tumor.
Connection Strength

0.023
  1. Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer. Clin Cancer Res. 2017 Mar 15; 23(6):1552-1563.
    View in: PubMed
    Score: 0.013
  2. Personalized ovarian cancer disease surveillance and detection of candidate therapeutic drug target in circulating tumor DNA. Neoplasia. 2014 Jan; 16(1):97-103.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.